EndPoints News
Endpoints News is a leading source for up-to-the-minute biopharma industry news, offering in-depth reporting on the science, business, and people driving innovation.
Latest Headlines:
- FDA asks for more data on Lilly’s Foundayo to assess heart, liver risks
- Replimune looks ahead as repeat CRL speeds the company's decline
- Revolution Medicines leads latest wave of stock offerings, totaling $1.5B
- Endpoints biopharma sentiment survey for Q2 2026
- Harbinger raises $100M; Astellas to close Seattle site
- J&J increasingly confident it can manage Stelara cliff, but work remains
- Eli Lilly to pay up to $300M for cancer biotech CrossBridge Bio